Document ID: chunk:federal_register_of_legislation:F2024L01521:clause:1_41
Version: federal_register_of_legislation:F2024L01521
Segment Type: clause
Provision Reference: sch 1 cl 41
Character Range: 25427–26328

41  Schedule 1 (table)
After:
Tenofovir  Tablet containing tenofovir disoproxil maleate 300 mg  Oral  Tenofovir Disoproxil Viatris  after 31 January 2025— 4 months stock by reference to usual demand of both Tenofovir Disoproxil Viatris and Tenofovir Disoproxil Mylan added together

insert:
Tenofovir with emtricitabine  Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg  Oral  Tenofovir/Emtricitabine 300/200 APOTEX  3 months stock by reference to usual demand of both Tenofovir/Emtricitabine 300/200 APOTEX and TENOFOVIR/EMTRICITABINE 300/200 ARX added together
Tenofovir with emtricitabine  Tablet containing tenofovir disoproxil fumarate 300 mg with emtricitabine 200 mg  Oral  TENOFOVIR/EMTRICITABINE 300/200 ARX     3 months stock by reference to usual demand of both Tenofovir/Emtricitabine 300/200 APOTEX and TENOFOVIR/EMTRICITABINE 300/200 ARX added together